COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Website maintenance The PDA website will be unavailable during a 1 hour window due to scheduled maintenance between 00:00am and 06:00am on the Tuesday 27th of February 2024

Home  »   Latest News   »   PDA responds to GPhC fee decision

PDA responds to GPhC fee decision

The PDA is disappointed that the GPhC have not amended their fee proposal after considering multiple consultation responses which opposed their plans.

Wed 15th November 2023 The PDA

Before submitting a response to the GPhC consultation on potential fee increases the PDA  listened to the views of pharmacists and more than 3,800 PDA members said what they thought. This informed the response the PDA submitted on behalf of all members. The PDA’s response can be found here.

PDA members in Great Britain are now making it clear that they are extremely disappointed that their regulator has consulted on an initial proposal, learned that the vast majority of respondents reject it with many raising concerns about equality implications, but has disregarded those concerns and decided to implement the proposal unchanged.

A flat percentage increase to all existing fees means that opportunities to address inequality and unfairness in the current fee structure have been missed.

The PDA reiterates a call for transparency in how the GPhC reached its decision, including:

  • Although their new smaller offices may be lower cost to occupy than their previous offices in the same premium district, registrants will want more information about alternative options that could have secured greater savings.
  • A key focus of the PDA consultation response was to remove inequality from the fee structure and the PDA reiterates its request that the GPhC publish in full their equality impact assessment.

These are just some aspects of greater transparency called for in the PDA submission.

The PDA will be further examining the information about how this decision was reached and in the meantime, pharmacists who disagree with this decision can contact the GPhC to let them know their views directly here or by emailing Info@pharmacyregulation.org.

Learn more

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)